Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + Esketamine for Perioperative Sleep in Breast Cancer
NCT05732064Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- May 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, esketamine in sleep disorder, sponsored by Peking University First Hospital. Started May 2023; status: completed.
02
Drugs
dexmedetomidineesketamine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT05732064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05732064.